{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/674ecc69acec010eef51a4ab/69e5d2d06e5b90839ad287e7?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"AI Discovering Medicines Humans Could Never Find: James Field - LabGenius Therapeutics","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/674ecc69acec010eef51a4ab/1778143151799-0bbb47f0-c1d4-49fd-bd9e-2e37b50b4263.jpeg?height=200","description":"<p>AI is beginning to uncover medicines that humans alone could never design.</p><p><br></p><p>This week on another episode of Leading Beyond the Lab, we host James Field, CEO and Founder of LabGenius Therapeutics, a company pioneering the use of machine learning, robotics, and synthetic biology to engineer the next generation of therapeutic antibodies.</p><p><br></p><p>With over a decade of experience spanning AI-driven drug discovery, protein engineering, and synthetic biology, James founded LabGenius Therapeutics to rethink how biologic medicines are discovered. </p><p><br></p><p>In this episode, James discusses:</p><p><br></p><p>- The founding story of LabGenius Therapeutics and how its AI-guided experimentation platform is transforming antibody engineering.</p><p>- The companies backing by leading investors including Kindred Capital (Leila Zegna), Lux Capital, Obvious Ventures, M Ventures, and Octopus Ventures, and is guided by industry leaders such as Edwin Moses, the company’s Chairman and a veteran biotech executive.</p><p>- LabGenius Therapeutics' collaboration with Sanofi, and how partnerships between biotech startups and global pharma companies are helping translate AI-designed antibodies into real therapeutic pipelines.</p><p>- The importance of global scientific conferences such as European Society for Medical Oncology, where breakthroughs in oncology and biologics are shaping the future of therapeutic development.</p><p>- The mentors and inspirations that shaped his journey into biotech, from his university lecturers at Imperial College London to industry leaders like Edwin Moses, who now serves as Chairman of LabGenius Therapeutics and has played a key role in guiding the company’s growth.</p><p><br></p><p>If you're interested in AI-driven drug discovery, biotech entrepreneurship, and the future of medicine, this episode is one you won’t want to miss.</p><p><br></p><p>Follow ARTO</p><p>LinkedIn: https://www.linkedin.com/company/artotalent</p><p>Spotify: https://open.spotify.com/show/0kEcRZOiJChOoN1KF2n1ng</p><p>Instagram: https://www.instagram.com/arto.talent?igsh=MWdhbWl5N204a253NQ%3D%3D&amp;utm_source=qr</p><p>TikTok: https://www.tiktok.com/@artotalent?_t=ZG-8tHbGACAZaj&amp;_r=1</p><p>Apple Podcasts: https://podcasts.apple.com/us/podcast/leading-beyond-the-lab/id1783115575</p><p>Website: https://arto-talent.com/</p><p>Youtube: https://www.youtube.com/@artotalent</p><p><br></p><p>Dr. James Field</p><p>LinkedIn: https://www.linkedin.com/in/james-field-7518a05b/</p><p><br></p><p>Lawrence Rose</p><p>Co-Founder + Talent Solutions Director At ARTO</p><p>LinkedIn: https://www.linkedin.com/in/lawrencerose/</p><p><br></p><p>Timestamps:</p><p>02:40 Rewriting the Rules of Drug Discovery</p><p>16:21 Scaling Innovation</p><p>37:29 AI, Motivation &amp; Purpose</p>","author_name":"ARTO Talent"}